Hamrick Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Hamrick Investment Counsel's AMGN Position: Q1 2026 in Review
Hamrick Investment Counsel increased its Amgen (AMGN) stake by 17% in Q1 2026, buying an estimated $508K and bringing the position to 9,826 shares worth $3.46M. The position accounts for 1.92% of the portfolio, ranked #15.
Hamrick Investment Counsel first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Hamrick Investment Counsel held 9,826 shares of Amgen worth $3.46M as of Q1 2026.
- Hamrick Investment Counsel bought 1,426 Amgen shares in Q1 2026, an estimated $508K.
- Amgen made up 1.92% of Hamrick Investment Counsel's portfolio in Q1 2026, its #15 holding.
- Hamrick Investment Counsel first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Hamrick Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.